InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 12.84 CNY -3.75% Market Closed
Market Cap: 10.8B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

InnoCare Pharma Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InnoCare Pharma Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
InnoCare Pharma Ltd
SSE:688428
Total Liabilities & Equity
ÂĄ10.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Total Liabilities & Equity
ÂĄ41.1B
CAGR 3-Years
4%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Liabilities & Equity
ÂĄ15.7B
CAGR 3-Years
65%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Total Liabilities & Equity
ÂĄ32.4B
CAGR 3-Years
7%
CAGR 5-Years
23%
CAGR 10-Years
23%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Liabilities & Equity
ÂĄ54.8B
CAGR 3-Years
32%
CAGR 5-Years
43%
CAGR 10-Years
36%
Imeik Technology Development Co Ltd
SZSE:300896
Total Liabilities & Equity
ÂĄ6.9B
CAGR 3-Years
14%
CAGR 5-Years
71%
CAGR 10-Years
N/A

See Also

What is InnoCare Pharma Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
10.3B CNY

Based on the financial report for Dec 31, 2022, InnoCare Pharma Ltd's Total Liabilities & Equity amounts to 10.3B CNY.

What is InnoCare Pharma Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 1Y
39%

Over the last year, the Total Liabilities & Equity growth was 39%.

Back to Top